• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    1/29/24 2:09:05 PM ET
    $ACON
    $ARVL
    $BE
    $BFRG
    Medical Specialities
    Health Care
    Auto Manufacturing
    Consumer Discretionary
    Get the next $ACON alert in real time by email

    Shares of Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.

    Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Palisade Bio, Inc. (NASDAQ:PALI) shares jumped 133.8% to $1.2250 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress.
    • OneMedNet Corporation (NASDAQ:ONMD) surged 95% to $1.0401. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) shares climbed 65.8% to $16.37.
    • Rail Vision Ltd. (NASDAQ:RVSN) gained 60% to $15.12.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) jumped 43% to $0.2200.
    • Enviva Inc. (NYSE:EVA) surged 35.3% to $0.7830.
    • Cardlytics, Inc. (NASDAQ:CDLX) surged 28% to $7.40 after the company announced it entered into a settlement agreement with SRS and updated preliminary Q4 2023 results.
    • Lucid Group, Inc. (NASDAQ:LCID) gained 23% to $3.2703.
    • Nyxoah S.A. (NASDAQ:NYXH) rose 22.5% to $11.53.
    • Spectral AI, Inc. (NASDAQ:MDAI) climbed 20.2% to $3.2580 after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) rose 20% to $9.16 after the company reported better-than-expected quarterly revenue.
    • Selina Hospitality PLC (NASDAQ:SLNA) gained 20% to $0.3310.
    • Science 37 Holdings, Inc. (NASDAQ:SNCE) jumped 16.4% to $5.68 as the company agreed to be acquired by eMed.
    • Volcon, Inc. (NASDAQ:VLCN) rose 16% to $0.1411.
    • Fisker Inc. (NYSE:FSR) gained 12.8% to $0.9063.
    • Evolus, Inc. (NASDAQ:EOLS) gained 12.4% to $13.41 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $16.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) gained 9.7% to $0.6818.
    • Horace Mann Educators Corporation (NYSE:HMN) gained 9% to $38.13. Keefe, Bruyette & Woods analyst Meyer Shields upgraded Horace Mann Educators from Market Perform to Outperform.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares rose 7.9% to $0.2783 after dipping 12% on Friday.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) surged 7.5% to $0.5378. 60 Degrees Pharmaceuticals recently announced that, following a Type C meeting held on Jan. 17, 2024, with the FDA, the company will move forward with a pivotal clinical study of tafenoquine in hospitalized babesiosis patients in the U.S.

    Losers

    • SMX (Security Matters) Public Limited Company (NYSE:SMX) fell 24.2% to $0.3259 after gaining around 83% on Friday.
    • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) shares declined 23.4% to $0.1710 after surging 17% on Friday.
    • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) fell 22.6% to $5.44. Bullfrog AI filed shelf offering of 786,938 shares and accompanying warrants at $6.63/share and accompanying warrant.
    • Psyence Therapeutics Corp. (NASDAQ:PBM) declined 19.1% to $1.90.
    • Meta Materials Inc. (NASDAQ:MMAT) declined 18.4% to $4.7501.
    • Aclarion, Inc. (NASDAQ:ACON) shares fell 18.2% to $2.32 after surging 52% on Friday.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) fell 17.4% to $24.33. Corbus Pharmaceuticals shares jumped 249% on Friday after the company announced data from the first-in-human clinical study of CRB-701 is being presented as a poster by its development partner CSPC Pharmaceutical at ASCO GU 2024.
    • Richtech Robotics Inc. (NASDAQ:RR) fell 17% to $2.8813.
    • Arrival (NASDAQ:ARVL) fell 14.1% to $0.6346.
    • J-Long Group Limited (NASDAQ:JL) dipped 12.4% to $8.80 amid post-IPO volatility.
    • TAL Education Group (NYSE:TAL) fell 10.5% to $10.52. The company recently posted upbeat quarterly sales.
    • Cyngn Inc. (NASDAQ:CYN) shares declined 10.4% to $0.2381 after gaining around 24% on Friday.
    • MINISO Group Holding Limited (NYSE:MNSO) fell 10.3% to $17.76.
    • GigaCloud Technology Inc. (NYSE:GCT) declined 10.1% to $23.03.
    • New Oriental Education & Technology Group Inc (NYSE:EDU) dipped 7.7% to $73.77. New Oriental recently reported better-than-expected second-quarter sales results.
    • Privia Health Group, Inc. (NASDAQ:PRVA) fell 7.7% to $21.09.
    • Bloom Energy Corporation (NYSE:BE) fell 7.5% to $11.53 after B of A Securities downgraded the stock from Neutral to Underperform.
    • Koninklijke Philips N.V. (NYSE:PHG) shares dipped 6% to $21.41 after the company reported fourth-quarter results and agreed on a settlement with the FDA, primarily focusing on Philips Respironics’ business operations in the U.S.

     

     

    Now Read This: Bitcoin, Ethereum Edge Lower; Pyth Network Becomes Top Loser

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ARVL
    $BE
    $BFRG

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    3/19/2026$19.00Equal Weight
    Wells Fargo
    Lucid Group Inc.
    $LCID
    3/18/2026$17.00Buy
    Citigroup
    Lucid Group Inc.
    $LCID
    3/4/2026$10.00Underperform
    BofA Securities
    Palisade Bio Inc.
    $PALI
    2/25/2026$5.00Buy
    Stifel
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    More analyst ratings

    $ACON
    $ARVL
    $BE
    $BFRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on SoFi Technologies with a new price target

    Wells Fargo initiated coverage of SoFi Technologies with a rating of Equal Weight and set a new price target of $19.00

    3/19/26 8:27:12 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Citigroup initiated coverage on Lucid Group with a new price target

    Citigroup initiated coverage of Lucid Group with a rating of Buy and set a new price target of $17.00

    3/18/26 8:56:23 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    BofA Securities resumed coverage on Lucid Group with a new price target

    BofA Securities resumed coverage of Lucid Group with a rating of Underperform and set a new price target of $10.00

    3/4/26 8:38:27 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    $ACON
    $ARVL
    $BE
    $BFRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wu Lei

    4 - GigaCloud Technology Inc (0001857816) (Issuer)

    3/18/26 9:16:59 PM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Noto Anthony

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/18/26 8:16:42 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Lavet Robert S

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/18/26 8:16:36 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $ACON
    $ARVL
    $BE
    $BFRG
    SEC Filings

    View All

    SEC Form 6-K filed by MINISO Group Holding Limited

    6-K - MINISO Group Holding Ltd (0001815846) (Filer)

    3/19/26 8:30:43 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13D/A filed by Spectral AI Inc.

    SCHEDULE 13D/A - Spectral AI, Inc. (0001833498) (Subject)

    3/18/26 7:07:31 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Aclarion Inc.

    10-K - Aclarion, Inc. (0001635077) (Filer)

    3/18/26 4:57:42 PM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $ARVL
    $BE
    $BFRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

    Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Balance Sheet with Cash Runway into 2028 BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the company's

    3/19/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

    DALLAS, March 18, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received $31.7 million in funding from the Biomedical Advanced Research and Development Authority ("BARDA") to accelerate and support additional feature aspects for the Company's DeepView® System, its AI-driven burn wound imaging technology. As part of the ongoing partnership, Spectral AI has committed to provide an additional $9.7 million to the total overall development costs associated with these feature advancements.

    3/18/26 4:05:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $ACON
    $ARVL
    $BE
    $BFRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Chief Executive Officer Noto Anthony bought $1,001,515 worth of shares (56,000 units at $17.88), increasing direct ownership by 0.48% to 11,675,452 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/2/26 3:36:37 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Director Fetter Victor bought $149,540 worth of shares (3,500 units at $42.73), increasing direct ownership by 19% to 22,292 units (SEC Form 4)

    4 - HORACE MANN EDUCATORS CORP /DE/ (0000850141) (Issuer)

    2/27/26 2:17:53 PM ET
    $HMN
    Property-Casualty Insurers
    Finance

    $ACON
    $ARVL
    $BE
    $BFRG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $ACON
    $ARVL
    $BE
    $BFRG
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call

    DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2025 on Tuesday, March 24, 2026 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results. Investors interested in participating in the live call can dial: 833-890-6620 – U.S.412-564-3789 – International A simultaneous webcast of the call may be access

    3/10/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

    Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 Mont-Saint-Guibert, Belgium – March 5 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the fourth quarter and full year of 2025 on Thursday, March 19, 2026. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET. A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or

    3/5/26 4:05:00 PM ET
    $NYXH
    Medical/Dental Instruments
    Health Care

    $ACON
    $ARVL
    $BE
    $BFRG
    Leadership Updates

    Live Leadership Updates

    View All

    GigaCloud Technology Inc Announces Appointment of U.S. Auditor

    EL MONTE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (NASDAQ:GCT) ("GigaCloud" or the "Company"), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that its Audit Committee has appointed Grant Thornton LLP, a U.S.-based audit firm, as the Company's new independent registered public accounting firm, subject to the completion of Grant Thornton's client acceptance and independence procedures and execution of an engagement letter. The appointment follows the dismissal of the Company's independent registered public accounting firm, KPMG Huazhen LLP. The change reflects the Company's ongoing efforts to align

    3/3/26 7:00:00 AM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACON
    $ARVL
    $BE
    $BFRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by GigaCloud Technology Inc

    SC 13D/A - GigaCloud Technology Inc (0001857816) (Subject)

    12/12/24 3:02:53 PM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 6:41:20 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care